Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region

Journal of Human Hypertension
B StrauchJ Widimsky

Abstract

Recently published studies from different parts of the world report significantly higher prevalence of primary hyperaldosteronism (PH) in hypertensives (ranging from 5 to 25%) than the previously accepted figures. There have been no data so far about the prevalence of PH in Central Europe. Therefore, we have undertaken this study to evaluate the prevalence of PH in patients with moderate to severe hypertension referred to a hypertension unit in the Czech Republic, together with the determination of the percentage of different subtypes of PH including familial forms. In addition to that, we have evaluated the prevalence of other types of secondary forms of hypertension.A total of 402 consecutive patients (230 females and 172 males) with hypertension, referred to our hypertension unit, were studied. Positive aldosterone/renin ratio (ARR, (ng/100 ml)/(ng/ml/h)) >/=50 as a more strict marker of PH was found in 87 patients (21.6%), 30% of them were normokalaemic. The diagnosis of PH was later confirmed in 77 cases (89%); the total prevalence of PH was thus 19%. PH consisted of the following forms: idiopathic hyperaldosteronism 42%, unilateral aldosterone-producing adenoma 36%, unilateral hyperplasia 7%, nonclassifiable PH (refused o...Continue Reading

References

May 1, 1993·Clinical and Experimental Pharmacology & Physiology·R D GordonS A Klemm
Dec 17, 1998·The New England Journal of Medicine·A Ganguly
Jan 5, 2000·Journal of Human Hypertension·T SeemanR Bernhardt
May 24, 2000·Journal of Human Hypertension·P O LimT M MacDonald
May 17, 2001·Current Hypertension Reports·M Stowasser
Sep 27, 2001·World Journal of Surgery·R D GordonJ C Rutherford

❮ Previous
Next ❯

Citations

Apr 20, 2007·Current Hypertension Reports·Murray Epstein, David A Calhoun
Jan 8, 2008·Current Hypertension Reports·Eduardo Pimenta, David A Calhoun
Oct 31, 2008·Current Hypertension Reports·Carolina C Gonzaga, David A Calhoun
Sep 17, 2011·Current Hypertension Reports·Gary E Sander, Thomas D Giles
Jun 26, 2013·Trends in Endocrinology and Metabolism : TEM·Sandi-Jo GalatiAlice C Levine
Oct 12, 2010·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yuji ItoYoshiyu Takeda
Jun 6, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Gavin J BeckerAnastasia Chrysostomou
Nov 23, 2006·Kidney & Blood Pressure Research·Jiri Widimský
Sep 11, 2012·BMC Endocrine Disorders·Helga Agusta SigurjonsdottirGudmundur Johannsson
Mar 10, 2007·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Masao OmuraTetsuo Nishikawa
Jul 10, 2013·Vascular Health and Risk Management·Jason L GuichardMustafa I Ahmed
Aug 13, 2011·International Journal of Hypertension·Riccardo Maria Fagugli, Chiara Taglioni
Oct 18, 2005·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Nicholas Daunt
Oct 25, 2012·Annual Review of Medicine·David A Calhoun
Feb 19, 2011·International Journal of Hypertension·Costas TsioufisChristodoulos Stefanadis
Feb 19, 2011·International Journal of Hypertension·Maria Czarina Acelajado, David A Calhoun
Jun 14, 2013·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Christian OttRoland E Schmieder
Apr 4, 2014·Journal of Human Hypertension·K NanbaM Naruse
Aug 29, 2014·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Chikako NakamaHiromi Rakugi
Mar 23, 2011·International Journal of Hypertension·Charles FaselisVasilios Papademetriou
May 27, 2014·The Surgical Clinics of North America·Adrian M Harvey
Feb 14, 2013·Heart, Lung & Circulation·Michael Stowasser, Richard Douglas Gordon
Aug 7, 2012·Best Practice & Research. Clinical Endocrinology & Metabolism·Yuji ItoYoshiyu Takeda
Apr 24, 2012·The Canadian Journal of Cardiology·Donald ClarkDavid A Calhoun
May 14, 2011·Endocrinology and Metabolism Clinics of North America·Gary L Schwartz
Dec 1, 2010·Best Practice & Research. Clinical Endocrinology & Metabolism·Marcus Quinkler, Paul M Stewart
Oct 13, 2010·Cardiology Clinics·Maria Czarina Acelajado, David A Calhoun
Jul 14, 2010·Cardiology Clinics·David A Calhoun, Kumar Sharma
Mar 17, 2010·Progress in Cardiovascular Diseases·Adam Whaley-ConnellJames R Sowers
Mar 3, 2009·Progress in Cardiovascular Diseases·Eduardo PimentaSuzanne Oparil
Jan 13, 2009·Current Problems in Cardiology·Krishna K GaddamDavid A Calhoun
Mar 8, 2016·Current Hypertension Reports·Eduardo Pimenta, David A Calhoun
Oct 26, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·A Advani, R Taylor
Aug 10, 2007·ANZ Journal of Surgery·Tony C PangMark S Sywak
Jan 13, 2012·The Journal of Clinical Hypertension·Maria Czarina AcelajadoDavid A Calhoun
Jun 10, 2014·European Journal of Clinical Investigation·Labrini PapanastasiouGeorge Piaditis
May 18, 2004·The Surgical Clinics of North America·Maha Al Fehaily, Quan-Yang Duh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.